Literature DB >> 7535210

Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest.

C D'Arrigo1, J J Candal-Couto, M Greer, D J Veale, J M Woof.   

Abstract

Human polymorphonuclear cells (PMN) were found to adhere to a novel model of blood vessel wall-associated IgG. The internal surfaces of cellulose acetate hollow fibres, of comparable internal diameter to small blood vessels, were coated with normal serum human IgG, heat-aggregated IgG (HAIgG), laminin or fibrinogen. Under conditions of flow mimicking those in a small vessel, PMN were found to adhere markedly only to immunoglobulin-coated fibres. Arrest on HAIgG was inhibited by excess soluble IgG but not by bovine serum albumin (BSA), demonstrating that the adhesion was IgG-specific and presumably mediated by Fc gamma R on the PMN surface. Pre-adsorption of serum components onto HAIgG-coated fibres enhanced PMN arrest, due most probably to fixation of complement components by immobilized HAIgG, resulting in additional potential to entrap PMN via complement receptors such as CR3. Treatment of PMN with the regulatory neuropeptide substance P also enhanced adhesion to HAIgG-coated fibres and caused increased surface expression of Fc gamma RI, Fc gamma RII and Fc gamma RIII. A mouse cell line derived from L cells, hR4C6, stably transfected with human Fc gamma RII, was found to adhere under flow to HAIgG-coated fibres, whilst untransfected parent L cells did not. This adhesion was similarly inhibited by excess soluble IgG, confirming the capability of Fc gamma R to mediate cell arrest. The study strongly suggests that Fc gamma R may play an important role in intravascular PMN arrest and we speculate that in inflammatory diseases PMN may adhere via Fc gamma R to immobilized immunoglobulin on the vascular endothelium, with subsequent degranulation and tissue damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535210      PMCID: PMC1534271          DOI: 10.1111/j.1365-2249.1995.tb03620.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Molecular cloning of a human immunoglobulin G Fc receptor.

Authors:  M L Hibbs; L Bonadonna; B M Scott; I F McKenzie; P M Hogarth
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

2.  Substance P and arthritis: analysis of plasma and synovial fluid levels.

Authors:  K W Marshall; B Chiu; R D Inman
Journal:  Arthritis Rheum       Date:  1990-01

3.  Heat-induced aggregated human IgG modifies the adherence of human polymorphonuclear cells to cultured endothelium.

Authors:  K A Brown; D McCarthy; M Bull; R C Chasty; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

4.  Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

Authors:  C W Smith; S D Marlin; R Rothlein; C Toman; D C Anderson
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Human neutrophil aggregation and increased adherence to human endothelial cells induced by heat-aggregated IgG and immune complexes.

Authors:  Y Hashimoto; E R Hurd
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

Review 6.  Complement deficiency: predisposing factor to autoimmune syndromes.

Authors:  J P Atkinson
Journal:  Clin Exp Rheumatol       Date:  1989 Sep-Oct       Impact factor: 4.473

7.  Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells.

Authors:  D B Cines; A P Lyss; M Bina; R Corkey; N A Kefalides; H M Friedman
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

Review 8.  Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.

Authors:  J D Smiley; S E Moore
Journal:  Am J Med Sci       Date:  1989-10       Impact factor: 2.378

Review 9.  Cytotoxicity mediated by human Fc receptors for IgG.

Authors:  M W Fanger; L Shen; R F Graziano; P M Guyre
Journal:  Immunol Today       Date:  1989-03

10.  The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

Authors:  J A Schifferli; Y C Ng; J P Paccaud; M J Walport
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

View more
  20 in total

Review 1.  The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.

Authors:  H Hanai; Y Takeda; M Eberhardson; R Gruber; A R Saniabadi; O Winqvist; R Lofberg
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

2.  Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins.

Authors:  Hicham Bouhlal; Denis Martinvalet; Jean-Luc Teillaud; Catherine Fridman; Michel D Kazatchkine; Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2014-04-01       Impact factor: 8.317

3.  Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

Authors:  V Muratov; J Lundahl; A K Ulfgren; K Elvin; I Fehrman; N Ahlborg; A Ost; N Hittel; A Saniabadi; R Löfberg
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

4.  Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis.

Authors:  Grit Waitz; Sebastian Petermann; Stefan Liebe; Joerg Emmrich; Wolfgang Ramlow
Journal:  Dig Dis Sci       Date:  2008-02-06       Impact factor: 3.199

Review 5.  Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.

Authors:  Hiroyuki Hanai
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

6.  Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.

Authors:  T Pankhurst; G Nash; J Williams; R Colman; A Hussain; C Savage
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

7.  Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Takayuki Iida; Masami Yamada; Yoshihiko Sato; Ken Takeuchi; Tatsuo Tanaka; Kenji Kondo; Masataka Kikuyama; Yasuhiko Maruyama; Yasushi Iwaoka; Akiko Nakamura; Kazuhisa Hirayama; Abby R Saniabadi; Fumitoshi Watanabe
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 8.  Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.

Authors:  Abbi R Saniabadi; Tomotaka Tanaka; Toshihide Ohmori; Koji Sawada; Takayuki Yamamoto; Hiroyuki Hanai
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

9.  Leukocytapheresis: An "Out-of-Body" Experience in Inflammatory Bowel Disease.

Authors:  Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-12

10.  Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Ken Takeuchi; Takayuki Iida; Nobuhito Kashiwagi; Abby R Saniabadi; Isao Matsushita; Yoshihiko Sato; Naoki Kasuga; Toshihiro Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.